These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31862827)

  • 1. Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154.
    Trinh B; Donath MY; Läubli H
    Diabetes Care; 2020 Jan; 43(1):e11. PubMed ID: 31862827
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154.
    Galligan A; Krishnamurthy B; Kay TW
    Diabetes Care; 2020 Jan; 43(1):e10. PubMed ID: 31862826
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes. Diabetes Care 2018;41:e150-e151.
    Jørgensen LB; Yderstræde K
    Diabetes Care; 2019 May; 42(5):e77. PubMed ID: 31010946
    [No Abstract]   [Full Text] [Related]  

  • 4. Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis.
    Esfahani K
    J Immunother Cancer; 2018 Dec; 6(1):154. PubMed ID: 30577825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab.
    Trinh B; Donath MY; Läubli H
    Diabetes Care; 2019 Sep; 42(9):e153-e154. PubMed ID: 31308021
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Immune Checkpoint Inhibitor Induced Colitis with Infliximab.
    Tidwell C; Gutnik S
    S D Med; 2019 Oct; 72(10):454-458. PubMed ID: 31816206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.
    Prieux-Klotz C; Dior M; Damotte D; Dreanic J; Brieau B; Brezault C; Abitbol V; Chaussade S; Coriat R
    Target Oncol; 2017 Jun; 12(3):301-308. PubMed ID: 28540478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
    Ferrannini E; Mark M; Mayoux E
    Diabetes Care; 2016 Nov; 39(11):e196-e197. PubMed ID: 27926896
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.
    Bode BW; Bowering K; Russell-Jones D
    Diabetes Care; 2018 Mar; 41(3):e29-e30. PubMed ID: 29463670
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to: Letter to the Editor by Trinh et al. Drug-induced liver injury registries are important.
    Björnsson ES; Lucena MI; Andrade RJ; Aithal GP
    Liver Int; 2023 Oct; 43(10):2325-2326. PubMed ID: 37592875
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab.
    Zhang HC; Luo W; Wang Y
    J Immunother Cancer; 2019 Feb; 7(1):47. PubMed ID: 30777137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.
    Wu T; Marathe CS; Horowitz M; Jones KL; Rayner CK
    Diabetes Care; 2018 Mar; 41(3):e27-e28. PubMed ID: 29463669
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
    Ceriello A; Genovese S; Mannucci E; Gronda E
    Diabetes Care; 2016 Nov; 39(11):e195. PubMed ID: 27926895
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction: Trinh, H.V., et al. Humoral Response to the HIV-1 Envelope V2 Region in a Thai Early Acute Infection Cohort.
    Trinh HV; Gohain N; Pham PT; Hamlin C; Song H; Sanders-Buell E; Bose M; Eller LA; Jain S; Uritskiy G; Rao VB; Tovanabutra S; Michael NL; Robb ML; Joyce MG; Rao M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31174408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do infliximab and methotrexate act synergistically in the treatment of rheumatoid arthritis? Comment on the article by Maini et al.
    Rezaian MM
    Arthritis Rheum; 1999 Aug; 42(8):1779-81. PubMed ID: 10446883
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
    Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
    Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson.
    Wang Y; Abu-Sbeih H; Mao E; Ali N; Ali FS; Qiao W; Lum P; Raju G; Shuttlesworth G; Stroehlein J; Diab A
    J Immunother Cancer; 2018 May; 6(1):37. PubMed ID: 29747688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to: 'Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1' by Michot et al and 'Checkpoint inhibitor-associated immune arthritis' by Arnaud
    Kostine M; Richez C; Schaeverbeke T;
    Ann Rheum Dis; 2019 Jul; 78(7):e69. PubMed ID: 29934372
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum: Trinh et. al., Cellular and Network Mechanisms May Generate Sparse Coding of Sequential Object Encounters in Hippocampal-Like Circuits.
    eNeuro; 2020; 7(4):. PubMed ID: 32873558
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab.
    Ortega Sanchez G; Jahn K; Savic S; Zippelius A; Läubli H
    J Immunother Cancer; 2018 Sep; 6(1):85. PubMed ID: 30176946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.